text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "natural killer cells"
Too many choices? Use the filter option on the left to narrow your product listing.
31-40 of 779 results
    AccuGENE™ 5 M Sodium Chloride
    Compare
    AccuGENE™ 5 M Sodium Chloride
    Catalog #: 51202
    AccuGENETM 5M NaCl, 1 L
    EA
    AccuGENE<sup class=reg>®</sup> 0.5 M EDTA Solution
    Compare
    AccuGENE® 0.5 M EDTA Solution
    Catalog #: 51201

    AccuGENE® 0.5M EDTA Solution, 100 mL

    EA
    AccuGENE<sup class=reg>&reg;</sup> 0.5 M EDTA Solution
    Compare
    AccuGENE® 0.5 M EDTA Solution
    Catalog #: 51234

    AccuGENE® 0.5M EDTA Solution, 1 L

    EA
    AccuGENE™ 3 M Sodium Acetate
    Compare
    AccuGENE™ 3 M Sodium Acetate
    Catalog #: 51203
    AccuGENETM 3 M Sodium Acetate, pH 5.2, 500 mL
    EA
    Stepped Neutral Density Plate Recertification Service
    Compare
    Stepped Neutral Density Plate Recertification Service
    Catalog #: 85-012-SND

    Stepped Neutral Density Plate Recertification Service (additional wavelengths, not including 340 and 405 nm)

     

     

    EA
    Cryo Human Leukopak (2.5 Billion Cells)
    Compare
    Cryo Human Leukopak (2.5 Billion Cells)
    Catalog #: 260280.01
    Cryopreserved human leukapheresis product collected from normal peripheral blood, containing ≥2.5 billion cells
    BG
    Rat Neural Stem Cell Nucleofector<sup class=reg>®</sup> Kit
    Compare
    Rat Neural Stem Cell Nucleofector® Kit
    Catalog #: VPG-1005

    For efficient transfection of primary rat neural stem cells in the Nucleofector® I/II/2b System

    ST
    Mouse Neural Stem Cell Nucleofector<sup class=reg>®</sup> Kit
    Compare
    Mouse Neural Stem Cell Nucleofector® Kit
    Catalog #: VPG-1004

    For efficient transfection of primary mouse neural stem cells in the Nucleofector® I/II/2b Device

    ST
    P3 Primary Cell 4D-Nucleofector<sup class=reg>®</sup> LV Kit L
    Compare
    P3 Primary Cell 4D-Nucleofector® LV Kit L
    Catalog #: V4LP-3002
    For larger scale transfection of primary cells, e.g. human T cells or CD34+ hematopoietic stem cells in the 1 mL NucleocuvetteTM Cartridge format when working with the 4D-NucleofectorTM LV Unit
    SA
    DPSC - Human Dental Pulp Stem Cells
    Compare
    DPSC - Human Dental Pulp Stem Cells
    Catalog #: PT-5025

    Cryopreserved ampule of Human Dental Pulp Stem Cells containing ≥1 million cells

    AMP
1-10 of 1103 results
  • Natural Killer Cells Infographic
    Natural Killer cells have an innate ability to recognize and destroy non-self cells.
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • 3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
    Watch Video
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • TechSheet - Poietics™ Human Immune System Cells
    Technical Product Information Sheet
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.